Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-10-26
1980-08-19
Morgenstern, Norman
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424309, 424282, 560 45, 560 47, 560 48, 562452, 562456, 562457, 2603405R, A01N 920
Patent
active
042184754
ABSTRACT:
Substituted or unsubstituted benzylaminobenzene alkanoic or alkenoic acids are disclosed as hypolipidemic agents and especially as hypocholesterolemic agents; along with a method of use and pharmaceutical compositions thereof.
REFERENCES:
patent: 3673243 (1972-07-01), Yamamoto et al.
patent: 3766260 (1973-10-01), Carney et al.
patent: 3839433 (1974-10-01), Wasley
patent: 3919304 (1975-11-01), Rossi
patent: 3957850 (1976-05-01), Bouchara
patent: 4026896 (1977-05-01), Harita et al.
Derwent Abst., Be-863-156, (7-20-1978).
Matthews Donald P.
Renzi Alfred A.
Wagner Eugene R.
Morgenstern Norman
Reamer James H.
The Dow Chemical Company
LandOfFree
Hypolipidemic benzylaminobenzene alkanoic or alkenoic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypolipidemic benzylaminobenzene alkanoic or alkenoic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypolipidemic benzylaminobenzene alkanoic or alkenoic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1427915